PD-1 and PD-L1 immune checkpoint inhibitors (ICIs) for treating advanced cancer were associated with an increased risk of new-onset psoriasis, a large observational study from Taiwan found. In an ...

Psoriasis is a common condition of the skin resulting in redness, scaling, and itching. Sometimes it can be so severe that it prevents people from enjoying simple daily activities. In difficult cases ...

Psoriasis is more than a skin condition: It’s a chronic autoimmune disease that involves systemic inflammation. There’s also evidence that the skin condition may be associated with a higher risk of ...

A nationwide cohort study in Taiwan found a higher risk of psoriasis in cancer patients treated with immune checkpoint inhibitors compared to other therapies. The study analyzed data from 3,188 ...

HDAC inhibitors, already widely used to treat cancer, may be an effective therapy for psoriasis as well, scientists report. They have shown that HDAC3 inhibitors are particularly adept at increasing ...

A retrospective study investigated skin cancer risk in a large cohort of patients treated with ultraviolet light therapy between May 1977 and November 2018. Patients were treated with narrowband UVB ...

Major advancements in psoriasis treatments in the past two decades have given people living with the autoimmune condition a wide range of options for controlling symptoms. There are more than a dozen ...

Your skin is in a constant state of reinvention. Every month, your body sheds and regenerates its entire outer layer—a complete turnover powered by tiny, tireless stem cells. These same cells spring ...

Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2-3% of the global population. The condition is characterised by red, scaly ...

Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...